Mission
The International Society for Genetic Eye Diseases and Retinoblastoma (ISGEDR) is dedicated to bringing together individuals interested in the field of genetic diseases of the eye and Retinoblastoma. It aims to foster collaboration, inspire new researchers, and share advancements in ophthalmic genetics.
Basic Information
Tax-Exempt
Founded in
Not Reported
EIN
30-0065906
Total Assets
$141.5 thousand
At a Glance
ISGEDR 2025 Meeting Announcement
Announcing the ISGEDR biannual meeting from September 11-13, 2025, in Oslo, Norway.
Ophthalmic Genetics Study Club 2024 - Chicago
Join the hybrid meeting on October 17, 2024, focusing on advancements in genetic eye diseases.
Ophthalmic Genetics Subscription
Members of ISGEDR receive a free subscription to the Journal, Ophthalmic Genetics.
Upcoming Events
ISGEDR 2025 Meeting
2025-09-11
Biannual meeting focused on genetic eye diseases and retinoblastoma.
Learn MoreOphthalmic Genetics Study Club 2024
2024-10-17
A hybrid meeting with discussions on recent advances in genetic eye diseases.
Learn MoreMIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
43
44
/100
Program Expense Ratio
95.23%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
4.827
18
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 23.19K | 99.95% |
| Program Services | 0 | 0.00% |
| Investment Income | 11 | 0.05% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 23.2K | 100.00% |
